Business Context and Reporting Period
Company: Ball Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: May 17, 2016
Reporting Period: Event-specific (May 17, 2016)
This filing serves as a Regulation FD disclosure regarding the publication of a U.K. Prospectus. The prospectus relates to shares of Ball common stock to be issued as consideration for the proposed acquisition of all issued and to-be-issued share capital of Rexam PLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the availability of the U.K. Prospectus rather than a financial results report.
Material Changes
Acquisition Activity: Ball Corporation has published a U.K. Prospectus to facilitate its previously announced offer to acquire Rexam PLC. The consideration for this transaction involves the issuance of Ball common stock to Rexam shareholders.
Guidance, Outlook, and Risks
Forward-Looking Statements: The filing contains forward-looking statements subject to risks and uncertainties. Ball undertakes no obligation to update these statements.
Key Risks and Uncertainties:
- Acquisition Risks: Failure to satisfy conditions for the Rexam acquisition, including receipt of regulatory approvals; failure to complete the sale of proposed divested assets required for regulatory approval; termination of the definitive agreement; and legal proceedings related to the agreement.
- Operational Risks (Packaging): Product demand fluctuations, raw material costs, competitive pricing, climate changes, crop yields, and regulatory changes (e.g., deposit laws).
- Operational Risks (Aerospace): Government and commercial contract funding, authorization, and technical uncertainties.
- General Corporate Risks: Changes in senior management, regulatory actions (FDA, environmental, safety), litigation, labor costs, pension plan performance, and interest rate fluctuations affecting debt.
Investor Verification Checklist
- Review the U.K. Prospectus (Exhibit 99.1) for detailed terms of the Rexam acquisition and share issuance.
- Verify the status of regulatory approvals required to complete the Rexam acquisition.
- Confirm the progress of the sale of proposed divested assets necessary for regulatory clearance.
- Assess potential impacts of the acquisition announcement on Ball's existing business relationships and operating results.